Pomahope 2mg capsules | Pomalidomide |Millionpharma
POMAHOPE 2MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 2mg and it belongs to anti-neoplastic drugs Pomahope 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 2mg is used by combining with dexamethasone. Pomahope 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 2mg capsules treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activitie...